The role of sulfonylureas in type 2 diabetes

By  

Inpharma, Vol. 1, Iss. 1301, 2001-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Sulfonylureas may be associated with beneficial outcomes in patients with type II diabetes mellitus who experience an acute ischaemic stroke

By  

Inpharma, Vol. 1, Iss. 1610, 2007-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

The Therapeutic Potential of Rutin for Diabetes: An Update

By  

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 7, 2015-06 ,pp. : 524-528

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of CYP2C9 polymorphisms on prescribed dose and time-to-stable dose of sulfonylureas in primary care patients with Type 2 diabetes mellitus

By Swen Jesse J   Wessels Judith AM   Krabben Annemarie   Assendelft Willem JJ   Guchelaar Henk-Jan  

Pharmacogenomics, Vol. 11, Iss. 11, 2010-11 ,pp. : 1517-1523

Future Medicine

Access to resources Recommend Favorite

Editorial (Diabetes, Obesity and Vascular Disease - An Update)

By  

Current Pharmaceutical Design, Vol. 19, Iss. 27, 2013-08 ,pp. : 4900-4903

Bentham Science Publishers

Access to resources Recommend Favorite